{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:21:04Z","timestamp":1793370064240,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>\n                    Phosphaturic mesenchymal tumor (PMT) is a rare neoplasm of uncertain histogenesis that has been linked to tumor-induced osteomalacia (TIO) since 1959. The neoplastic cells produce increased amount of FGF23 which results in TIO via uncontrolled renal loss of phosphate (phosphaturia), and consequently diminished bone mineralization. To date, \u223c300 cases have been reported. Although there is increasing evidence that PMT can be diagnosed by reproducible histopathologic features, firm diagnosis has been often restricted to cases associated with TIO and, hence, diagnosis of \u201cnonphosphaturic variants\u201d remained challenging. Recently,\n                    <jats:italic toggle=\"yes\">FGFR1\/FN1<\/jats:italic>\n                    gene fusions were detected in roughly half of cases. We herein reviewed the clinicopathologic features of 22 PMTs (15 cases not published before), stained them with an extended immunohistochemical marker panel and examined them by fluorescence in situ hybridization for\n                    <jats:italic toggle=\"yes\">FGFR1<\/jats:italic>\n                    gene fusions. Patients were 12 males and 9 females (one of unknown sex) aged 33 to 83 years (median: 52 y). Lesions affected the soft tissues (n=11), bones (n=6), sinonasal tract (n=4), and unspecified site (n=1). Most lesions originated in the extremities (9 in the lower and 4 in the upper extremities). Acral sites were involved in 10 patients (6 foot\/heel, 3 fingers\/hands, and 1 in unspecified digit). Phosphaturia and TIO were recorded in 10\/11 and 9\/14 patients with detailed clinical data, respectively. Limited follow-up (5 mo to 14 y; median: 16 mo) was available for 14 patients. Local recurrence was noted in one patient and metastasis in another patient. Histologically, 11 tumors were purely of conventional mixed connective tissue type, 3 were chondromyxoid fibroma-like, 2 were hemangio-\/glomangiopericytoma-like with giant cells, and 1 case each angiomyolipoma-like and reparative giant cell granuloma-like. Four tumors contained admixture of patterns (predominantly cellular with variable conventional component). Immunohistochemistry showed consistent expression of CD56 (11\/11; 100%), ERG (19\/21; 90%), SATB2 (19\/21; 90%), and somatostatin receptor 2A (15\/19; 79%), while other markers tested negative: DOG1 (0\/17), beta-catenin (0\/14), S100 protein (0\/14), and STAT6 (0\/7).\n                    <jats:italic toggle=\"yes\">FGFR1<\/jats:italic>\n                    fluorescence in situ hybridization was positive in 8\/17 (47%) evaluable cases. These results add to the phenotypic delineation of PMT reporting for the first time consistent expression of SATB2 and excluding any phenotypic overlap with solitary fibrous tumor or sinonasal glomangiopericytoma. The unifying immunophenotype of the neoplastic cells irrespective of the histologic pattern suggests a specific disease entity with diverse morphotypes\/variants rather than different neoplasms unified by TIO.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000000890","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T12:29:27Z","timestamp":1497443367000},"page":"1371-1380","source":"Crossref","is-referenced-by-count":115,"title":["Phosphaturic Mesenchymal Tumors"],"prefix":"10.1097","volume":"41","author":[{"given":"Abbas","family":"Agaimy","sequence":"first","affiliation":[{"name":"Institute of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Michal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Prague"},{"name":"Biomedical Center of the Faculty of Medicine in Pilsen, Pilsen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simion","family":"Chiosea","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Petersson","sequence":"additional","affiliation":[{"name":"Department of Pathology, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Hadravsky","sequence":"additional","affiliation":[{"name":"Department of Pathology, 3rd Medical Faculty in Prague, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Kristiansen","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund E.","family":"Horch","sequence":"additional","affiliation":[{"name":"Department of Hand & Plastic Surgery, University Hospital, Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schmolders","sequence":"additional","affiliation":[{"name":"Department of Orthopedic & Traumatology, Section for Tumor Orthopedics, University Hospital, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Haller","sequence":"additional","affiliation":[{"name":"Institute of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Prague"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R2-20230922","first-page":"554","article-title":"Rachitis infolge knochentumors [Rickets caused by bone tumor]","volume":"14","author":"Prader","year":"1959","journal-title":"Helv Pediatr Acta"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(72)92844-9","article-title":"Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia","volume":"1","author":"Evans","year":"1972","journal-title":"Lancet"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM197204062861402","article-title":"Tertiary hyperparathyroidism and apparent \u201ccure\u201d of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx","volume":"286","author":"Olefsky","year":"1972","journal-title":"N Engl J Med"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors: a polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/1346-8138.12602","article-title":"Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work","volume":"41","author":"Honda","year":"2014","journal-title":"J Dermatol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12105-015-0668-3","article-title":"Phosphaturic mesenchymal tumor: 2 new oral cases and review of 53 cases in the head and neck","volume":"10","author":"Qari","year":"2016","journal-title":"Head Neck Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00428-005-0149-2","article-title":"Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis","volume":"448","author":"Shelekhova","year":"2006","journal-title":"Virchows Arch"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/PAS.0b013e3181d594fa","article-title":"Sinonasal phosphaturic mesenchymal tumor (mixed connective tissue variant): report of 2 cases","volume":"34","author":"Shelekhova","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12105-015-0678-1","article-title":"Phosphaturic mesenchymal tumor involving the head and neck: a report of five cases with FGFR1 fluorescence in situ hybridization analysis","volume":"10","author":"Wasserman","year":"2016","journal-title":"Head Neck Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/his.12872","article-title":"From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses","volume":"68","author":"Mok","year":"2016","journal-title":"Histopathology"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","article-title":"The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?","volume":"471","author":"Ledford","year":"2013","journal-title":"Clin Orthop Relat Res"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jclinpath-2012-200852","article-title":"Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas","volume":"65","author":"Graham","year":"2012","journal-title":"J Clin Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000000290","article-title":"A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors","volume":"39","author":"Carter","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13000-016-0477-3","article-title":"Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant","volume":"11","author":"Shiba","year":"2016","journal-title":"Diagn Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","article-title":"Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)","volume":"44","author":"Houang","year":"2013","journal-title":"Hum Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00795-015-0115-2","article-title":"ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors","volume":"49","author":"Tajima","year":"2016","journal-title":"Med Mol Morphol"},{"key":"R20-20230922","first-page":"8159","article-title":"CD56 may be a more useful immunohistochemical marker than somatostatin receptor 2A for the diagnosis of phosphaturic mesenchymal tumors","volume":"8","author":"Tajima","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R21-20230922","first-page":"9390","article-title":"Possibility of D2-40 as a diagnostic and tumor differentiation-suggestive marker for some of phosphaturic mesenchymal tumors","volume":"8","author":"Tajima","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2016-203893","article-title":"DOG1 expression in phosphaturic mesenchymal tumour","author":"Creytens","year":"2016","journal-title":"J Clin Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.12138","article-title":"SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours","volume":"63","author":"Conner","year":"2013","journal-title":"Histopathology"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.prp.2016.06.012","article-title":"The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas","volume":"212","author":"Machado","year":"2016","journal-title":"Pathol Res Pract"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PAP.0000000000000001","article-title":"SATB2 is a novel marker of osteoblastic differentiation and colorectal adenocarcinoma","volume":"21","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jclinpath-2014-202601","article-title":"ERG expression in chondrogenic bone and soft tissue tumours","volume":"68","author":"Shon","year":"2015","journal-title":"J Clin Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00256-011-1159-6","article-title":"Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance","volume":"40","author":"Suryawanshi","year":"2011","journal-title":"Skeletal Radiol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/modpathol.2014.161","article-title":"Nuclear expression and gain-of-function \u03b2-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker","volume":"28","author":"Lasota","year":"2015","journal-title":"Mod Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ajpath.2014.10.019","article-title":"Recurrent mutations within the amino-terminal region of \u03b2-catenin are probable key molecular driver events in sinonasal hemangiopericytoma","volume":"185","author":"Haller","year":"2015","journal-title":"Am J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201710000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:26:38Z","timestamp":1695407198000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201710000-00007"}},"subtitle":["Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum"],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000890","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}